275 WYMAN STREET, WALTHAM, MA
Market cap: $5.7B (2/09/2026)
Price: $37.77
Other Events
Cogent Biosciences Completes $230 Million Convertible Notes Offering
Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031
Investor Presentation
Reports Recent Business Highlights and Third Quarter 2025 Financial Results
News, Material Contracts
Reports Recent Business Highlights and Second Quarter 2025 Financial Results
Cogent Biosciences Reports Positive Results from SUMMIT Trial of Bezuclastinib
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Effectiveness Notice
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13D - Ownership Report
Free Writing Prospectus